Dokter Operasi kanker tenggorokan terbaik di dunia — TOP 40

Dr. Buhl adalah ahli bedah saraf ternama yang berspesialisasi dalam operasi otak dan sumsum tulang belakang yang kompleks, dengan fokus kuat pada neuro-onkologi dan teknik invasif minimal.

• Penulis 47 makalah ilmiah tentang neuropatologi
• Pakar dalam perawatan bedah untuk metastasis otak
• Salah satu pendiri dana penelitian tumor otak
• Melakukan operasi neuronavigasi berbantuan komputer
• Aktif dalam penelitian tentang kavernoma intrakranial

Prof. Andreas Sesterhenn berspesialisasi dalam perawatan hemat untuk tumor kepala, leher, dan saluran napas atas, melakukan bedah robotik dan endoskopi minimal invasif.

• Kepala Dokter THT, Bedah Kepala dan Leher di Klinik Solingen
• 26 tahun pengalaman bedah dalam onkologi THT
• Melakukan intervensi robotik melalui sayatan kecil 1 cm
• Penulis 78 publikasi ilmiah tentang perawatan THT
• Belajar di University of Health Sciences di Bethesda, AS

Spesialis kanker kepala dan leher dengan pelatihan fellowship di Hacettepe University Cancer Institute – salah satu pusat onkologi terkemuka di Turki.

• Berpengalaman dalam menangani berbagai jenis kanker termasuk kanker tenggorokan
• Terlatih di MD Anderson Cancer Center, University of Texas
• Bekerja di Hisar Hospital Intercontinental
• Menyelesaikan residensi di Istanbul Sisli Etfal Training and Research Hospital

Dr. Xavier Centeno Fornies memiliki pengalaman bedah lebih dari _doctor_8374_ tahun, termasuk pelatihan khusus di Mayo Clinic. Saat ini beliau memimpin departemen bedah di Centro Médico Teknon.

• Fellowship dalam bedah kolorektal di Cleveland Clinic Florida
• Mengikuti protokol ERAS untuk pemulihan lebih cepat setelah operasi
• Pakar dalam teknik laparoskopi tingkat lanjut
• Anggota American Society of Colon and Rectal Surgeons

Profesor Dan Fliss berspesialisasi dalam operasi kanker tenggorokan di Sourasky Medical Center (Ichilov).

• Onkolog berpengalaman dengan fokus pada kasus kanker tenggorokan
• Memegang gelar profesor, menunjukkan kualifikasi akademik yang tinggi
• Bekerja di salah satu pusat medis terkemuka di Israel

Dr. Viola Fox memimpin pusat kanker interdisipliner bersertifikat yang berspesialisasi dalam perawatan kanker tenggorokan tingkat lanjut.

• _doctor_6587_tahun_ sebagai hematolog, onkolog, dan imunolog
• Pakar dalam kemoterapi, imunoterapi, dan terapi target
• Aktif dalam penelitian biologi molekuler untuk perawatan kanker
• Anggota perkumpulan onkologi Jerman dan Amerika

Profesor Madya Tahsin Ozatli berspesialisasi dalam kanker payudara, paru-paru, dan gastrointestinal di Rumah Sakit Universitas Istinye Liv.

• Pengalaman lebih dari satu dekade di bidang onkologi
• Pernah bekerja di Klinik Onkologi Ankara dan Rumah Sakit Pelatihan dan Penelitian Regional Erzurum
• Dipromosikan menjadi Profesor Madya pada tahun 2016
• Menempuh pendidikan kedokteran di Universitas Selcuk

Dr. Alemdar berspesialisasi dalam operasi kanker tenggorokan di Medical Park Antalya Hospital Complex, dengan pelatihan ekstensif di bidang onkologi medis.

• Bersertifikat di bidang onkologi medis sejak 2018
• Lebih dari _doctor_9570_ tahun pengalaman dalam penyakit dalam dan onkologi
• Terlatih di Universitas Akdeniz, institusi terkemuka di Turki
• Bekerja di rumah sakit terakreditasi JCI dengan fasilitas onkologi canggih

Prof. Selin Kapan membawa lebih dari _doctor_10984_ tahun keahlian bedah dalam operasi kanker tenggorokan di İstinye University Liv Hospital Topkapı.

• Profesor Bedah Umum dengan kredensial akademik yang luas
• Telah menerbitkan 50+ makalah penelitian di jurnal peer-reviewed
• Anggota Asosiasi Bedah Hepato-Pankreato-Bilier Turki
• Terlatih di Fakultas Cerrahpaşa yang bergengsi di Universitas Istanbul

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

Profesor Madya di Rumah Sakit Medical Park Bahcelievler dengan pengalaman lebih dari 28 tahun dalam operasi kanker tenggorokan.

• Spesialis bedah umum dengan fokus pada prosedur THT
• Anggota dari berbagai perkumpulan bedah bergengsi termasuk Perkumpulan Bedah Turki
• Pelatihan ekstensif di Rumah Sakit Pelatihan dan Penelitian Göztepe Kementerian Kesehatan

Ahli bedah onkologi bersertifikat yang berspesialisasi dalam operasi kanker tenggorokan di Rumah Sakit Galenia.

• Terlatih di Centro Medico Nacional 20 de Noviembre Issste
• Anggota Sociedad Mexicana de Oncología
• Dosen universitas di Universidad Anahuac
• Bersertifikat oleh Conacem hingga 2030

Profesor Madya Cevper Ersoz berspesialisasi dalam bedah urologi invasif minimal di Rumah Sakit Distrik Medipol Acibadem.

• Pakar dalam bedah kanker urologi robotik dan laparoskopi
• Lebih dari 130 publikasi nasional dan internasional
• Anggota Asosiasi Urologi Eropa
• Terlatih di Departemen Urologi Universitas Michigan

Profesor Kyzas berspesialisasi dalam bedah kanker kepala dan leher, memelopori rekonstruksi personal yang dicetak 3D dengan tingkat keberhasilan tertinggi di Inggris.

• Terlatih dalam Bedah Mulut dan Maksilofasial di rumah sakit terkemuka di Inggris
• Memimpin uji coba MANTRA – studi terkontrol acak OMFS terbesar
• Penerima Penghargaan Keunggulan Klinis Nasional Perunggu
• Pemimpin Redaksi British Journal of Oral and Maxillofacial Surgery
• Bersertifikat dalam bedah mikrovaskular dan dukungan hidup trauma tingkat lanjut

Dr. Ahmer Arif Shaikh berspesialisasi dalam operasi kanker mulut dengan fokus pada pelestarian organ dan rehabilitasi fungsional di HCG Manavata Cancer Centre.

• 15 tahun pengalaman dalam Onkologi Bedah
• Keahlian dalam operasi maksilofasial dan kepala & leher utama
• Memiliki fellowship dalam Onkologi Bedah Kepala & Leher
• Peneliti dengan banyak publikasi
• Fokus pada kebersihan mulut preventif dan diagnosis dini

Pemegang rekor operasi robotik trans-oral di Asia – Prof. Dabas telah melakukan lebih dari 8.000 operasi kanker kepala, leher, dan toraks.

• 28 tahun spesialisasi dalam tumor kepala, leher, dan toraks
• Direktur Bedah Onkologi dan Kepala Bedah Robotik di BLK Cancer Centre
• Pakar bedah robotik untuk kanker mulut, faring, dan laring
• Anggota International Guild of Endoscopic and Robotic Head and Neck Surgery

Dr. Przemyslaw Ciesielski adalah seorang ahli bedah umum. Ia menyelesaikan spesialisasi pada tahun 2008. Ia lulus dari Universitas Kedokteran Warsawa pada tahun 1999. Ia meraih gelar Doktor Ilmu Kedokteran pada tahun 2010. Disertasinya mengevaluasi pemeriksaan klinis dan rektoskopi untuk mendiagnosis penyakit kolorektal pada pasien dengan peningkatan risiko kanker kolorektal.

Pelatihan proktologi dan kolorektalnya mencakup kursus formal dan fellowship. Ia menyelesaikan Kursus Proktologi di Rumah Sakit St. Rota di Vercelli pada tahun 2021 dan 2022, serta di Cologne pada tahun 2016. Ia menjalani fellowship klinis dalam Bedah Umum di Universitas Kedokteran Wina pada tahun 2014 dan di Universitas Magdeburg pada tahun 2015. Ia menjalani beberapa fellowship di Departemen Proktologi, Rumah Sakit Solec di Warsawa dari tahun 2005 hingga 2013. Ia menghadiri lokakarya bedah kolorektal tingkat lanjut di Poznan dan Lodz. Ia juga menyelesaikan kursus di Rumah Sakit St. Mark di London, termasuk "Frontiers in Colorectal Diseases" dan "Advanced Colorectal Workshop".

Dr. Paweł Grochowicz, MD, PhD, adalah seorang proktologis dengan pengalaman hampir 40 tahun. Beliau bekerja di Pusat Proktologi Warsawa di Rumah Sakit St. Elizabeth. Beliau menangani wasir, fistula dan abses anus, fisura anus, inkontinensia tinja, dan kista pilonidal. Beliau juga melakukan kolonoskopi dan polipektomi kolorektal.

Dari tahun 1979 hingga 2016, beliau bekerja di Unit Proktologi, Rumah Sakit Solec, sebuah pusat rujukan dan satu-satunya di Polandia. Sejak 2016, beliau bekerja di Pusat Proktologi Warsawa di Rumah Sakit St. Elizabeth. Di sana, beliau mengembangkan dan menerapkan metode baru serta menjalankan pekerjaan diagnostik, rehabilitasi, penelitian, dan pengajaran. Pusat ini merupakan kantor pusat Klub Koloproktologi Polandia.

Peran akademik dan penelitian: Institut Kedokteran Eksperimental dan Klinis, Akademi Ilmu Pengetahuan Polandia (1979–1997). Penerima beasiswa DAAD di LMU Munich (1983–1984). Rumah Sakit John Hunter, Universitas Newcastle, Australia (1989–1996). Di sana, beliau menjabat sebagai Direktur Unit Penelitian Transplantasi dan Pejabat Ilmiah Utama (1991–1996).